ALX Oncology Holdings Inc. Common Stock ALXO
$2.08
+5.58%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-80,890,000
- Net Margin
- —
- Return on Equity
- -59.40%
- Debt-to-Equity
- 0.07
- P/E Ratio
- —
- Price / Book
- 2.00
- Price / Sales
- —
Over the trailing twelve months, ALX Oncology Holdings Inc. Common Stock generated revenue of — and net income of $-80,890,000.
Key Stats
- Last Close
- $2.08
- Market Cap
- $272.41 million
- 52-Week Range
- $0.44 – $2.66
- Average Volume
- 1.01 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.